Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions
(NASDAQ: AXSM) Delayed: 241.97 -5.88 (2.37%)
Previous Close $247.85    52 Week High $15.74 
Open $247.85    52 Week Low $5.37 
Day High $252.03    P/E N/A 
Day Low $241.56    EPS $0.00 
Volume 1,312,941